Halozyme Therapeutics, Inc. · NASDAQ:HALO
Krishnan Mahesh sold 7,304 Halozyme Therapeutics, Inc. shares (Form 4)
Traded Jun 29, 2026 · Filed Jun 30, 2026
On Jun 29, 2026, Krishnan Mahesh (Director) sold 7,304 Halozyme Therapeutics, Inc. shares at US$75.00 for US$548K under a trading plan, leaving 14,462 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 7,304 shares
- Price
- US$75.00
- Value
- US$548K
- Holding after
- 14,462 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Option exercise | 7,304 | US$38.46 | 21,766 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 7,304 | US$75.00 | 14,462 | Direct |
Source
Related
- Halozyme Therapeutics, Inc.
- Krishnan Mahesh
- Halozyme Therapeutics, Inc. shareholders
- Form 4 · Krishnan Mahesh · May 7, 2026
- Form 4 · Torley Helen · Oct 8, 2026
- Form 4 · Posard Matthew L. · Oct 2, 2026
- Form 4 · Daly James M · Oct 2, 2026
- Form 4 · Posard Matthew L. · Sep 17, 2026
- Form 4 · Torley Helen · Sep 11, 2026